ARCHIVES

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 37 | October 9, 2009

Download PDF Visit The Full Archive

Related Articles

NCA Declines To Set Minimum Comp Center Bed Number

April 2, 1976

Under A Flat Budget, NIH Suspends Grant Increases, May restore Funds Later.

November 24, 2000

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

July 27, 2012

UCSF AIDS, Cancer Specimen Resource Bank Funded, Renamed

November 15, 2002

Tim Lee Carter Says He Wants Government To Abide By spirit Of 1971 Cancer Act

July 30, 1982

FDA Plans Greater Disclosures Over Wide Range Of Activities

May 21, 2010